zidovudine has been researched along with Bone Marrow Diseases in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (25.00) | 18.7374 |
| 1990's | 9 (75.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Groopman, JE; Scadden, DT; Wang, A; Zsebo, KM | 1 |
| Cao, G; Falguera, M; Perez-Mur, J; Puig, T | 1 |
| Bozzette, SA; Forthal, D; Kemper, C; Leedom, J; McCutchan, JA; Richman, DD; Sattler, FR; Tilles, JG | 1 |
| Back, DJ; Barry, M; Beeching, N; Breckenridge, AM; Howe, JL; Nye, F; Swart, AM; Weller, IV | 1 |
| Diasio, CR; Liu, T; Lu, Z; Soong, SJ; Zhang, R | 1 |
| Media, JE; Nakeff, A; Scheding, S | 1 |
| Phillips, NC; Tsoukas, C | 1 |
| Averett, DR; Burns, CL; Dornsife, RE; Huang, AT; Koszalka, GW; Panella, TJ; St Clair, MH | 1 |
| Carlisle, R; Sommadossi, JP; Weidner, DA; Xie, MY; Zhu, Z | 1 |
| Hotta, T; Inoue, T; Itoh, T; Nagai, Y; Ogura, M; Saitoh, H; Saneyoshi, M; Tomoda, Y; Tsushita, K; Yoshida, S | 1 |
| Brynes, RK; Causey, D; Gill, PS; Levine, AM; Loureiro, C; Rarick, M | 1 |
1 review(s) available for zidovudine and Bone Marrow Diseases
| Article | Year |
|---|---|
Pharmacologic studies of nucleosides active against the human immunodeficiency virus.
Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Bone Marrow Diseases; HIV; Humans; Nucleosides; Zidovudine | 1990 |
3 trial(s) available for zidovudine and Bone Marrow Diseases
| Article | Year |
|---|---|
Study of the role of vitamin B12 and folinic acid supplementation in preventing hematologic toxicity of zidovudine.
Topics: Adult; Anemia; Bone Marrow Diseases; CD4 Lymphocyte Count; Female; Folic Acid; Hematologic Diseases; HIV Infections; Humans; Leucovorin; Male; Neutropenia; Prospective Studies; Vitamin B 12; Zidovudine | 1995 |
The tolerance for zidovudine plus thrice weekly or daily trimethoprim-sulfamethoxazole with and without leucovorin for primary prophylaxis in advanced HIV disease. California Collaborative Treatment Group.
Topics: Adolescent; Adult; AIDS-Related Opportunistic Infections; Bone Marrow Diseases; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV Infections; Humans; Leucovorin; Male; Pneumonia, Pneumocystis; Proportional Hazards Models; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Zidovudine | 1995 |
Azidothymidine for AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Complex; Bone Marrow Diseases; Clinical Trials as Topic; Humans; Kinetics; Thymidine; Zidovudine | 1986 |
8 other study(ies) available for zidovudine and Bone Marrow Diseases
| Article | Year |
|---|---|
In vitro effects of stem-cell factor or interleukin-3 on myelosuppression associated with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Bone Marrow Diseases; Cell Division; Colony-Forming Units Assay; Erythroid Precursor Cells; Ganciclovir; Granulocyte-Macrophage Colony-Stimulating Factor; Granulocytes; Hematopoietic Cell Growth Factors; Hematopoietic Stem Cells; Humans; Interferon alpha-2; Interferon-alpha; Interleukin-3; Macrophages; Recombinant Proteins; Stem Cell Factor; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Zidovudine | 1994 |
Zidovudine pharmacokinetics in zidovudine-induced bone marrow toxicity.
Topics: Administration, Oral; Adult; Animals; Bone Marrow Diseases; Chromatography, High Pressure Liquid; HIV Infections; Humans; Male; Middle Aged; Zidovudine | 1994 |
The time of administration of 3'-azido-3'-deoxythymidine (AZT) determines its host toxicity with possible relevance to AZT chemotherapy.
Topics: Analysis of Variance; Animals; Blood Cell Count; Body Weight; Bone Marrow Diseases; Circadian Rhythm; Injections, Intraperitoneal; Lethal Dose 50; Male; Rats; Rats, Sprague-Dawley; Thymidine Kinase; Zidovudine | 1993 |
Acute toxic effects of 3'-azido-3'-deoxythymidine (AZT) on normal and regenerating murine hematopoiesis.
Topics: Animals; Bone Marrow; Bone Marrow Cells; Bone Marrow Diseases; Bone Marrow Transplantation; Cell Differentiation; Cell Division; Dose-Response Relationship, Drug; Erythrocytes; Erythroid Precursor Cells; Erythropoiesis; Female; Hematopoiesis; Hematopoietic Stem Cells; Infusions, Intravenous; Injections, Intravenous; Male; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Regeneration; Time Factors; Whole-Body Irradiation; Zidovudine | 1994 |
Liposomal encapsulation of azidothymidine results in decreased hematopoietic toxicity and enhanced activity against murine acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Animals; Bone Marrow; Bone Marrow Diseases; Drug Carriers; Female; Leukocyte Count; Liposomes; Lymphocyte Activation; Male; Mice; Mice, Inbred C57BL; Retroviridae Infections; RNA-Directed DNA Polymerase; Spleen; Zidovudine | 1992 |
Anti-human immunodeficiency virus synergism by zidovudine (3'-azidothymidine) and didanosine (dideoxyinosine) contrasts with their additive inhibition of normal human marrow progenitor cells.
Topics: Bone Marrow; Bone Marrow Cells; Bone Marrow Diseases; Cell Division; Colony-Forming Units Assay; Didanosine; Drug Synergism; Erythroid Precursor Cells; HIV; Humans; In Vitro Techniques; RNA-Directed DNA Polymerase; Stem Cells; Zidovudine | 1991 |
In vitro bone marrow toxicity of nucleoside analogs against human immunodeficiency virus.
Topics: Antiviral Agents; Bone Marrow Diseases; Colony-Forming Units Assay; Dideoxynucleosides; HIV; Humans; Nucleosides; Zalcitabine; Zidovudine | 1989 |
Azidothymidine associated with bone marrow failure in the acquired immunodeficiency syndrome (AIDS).
Topics: Acquired Immunodeficiency Syndrome; Adult; Antiviral Agents; Bone Marrow Diseases; Humans; Male; Middle Aged; Pancytopenia; Random Allocation; Thymidine; Zidovudine | 1987 |